• home
  • contact us
  • careers
  • employee login
  • profile
    • History
    • Business Model
      • Portfolio Model
      • Licensing
    • Management Team
    • Board of Directors
    • Consultative Committee
    • Professional Affiliations
  • products
    • Nimotuzumab
      • Science
      • Safety Profile
      • Clinical Trials
      • Consortium
      • Licensee Links
    • AeroLEF®
      • Science
      • Variable Dosing
      • Clinical Trials
    • CYT387
      • Science
      • Clinical Trials
    • CYT997
      • Science
      • Clinical Trials
    • Clinical Trials
    • Request Medical Info
  • investors
    • Financial Reports
    • Regulatory Filings
    • Stock Information
    • Press Releases
    • Calendar of Events
    • Presentations
    • Corporate Governance
    • Investor Contacts
    • Email Sign-up
    • F.A.Q.
  • patients
    • Nimotuzumab
      • Patients - Canada
      • Patients - USA
      • Patients - Worldwide
    • CYT387
    • CYT997
    • AeroLEF®
  • physicians
    • Nimotuzumab
    • CYT387
    • CYT997
    • AeroLEF®
  • contact
    • Investor Contacts
    • Licensing Contact
    • Clinical Contact
  • Business Model
    • Portfolio Model
    • Licensing
  • Nimotuzumab
    • Nimotuzumab Overview
    • Science
    • Safety Profile
    • Clinical Trials
    • Consortium
  • AeroLEF®
    • AeroLEF® Overview
    • Science
    • Dosing
    • Clinical Trials
  • CYT387
    • CYT387 Overview
    • Science
    • Clinical Trials
  • CYT997
    • CYT997 Overview
    • Science
    • Clinical Trials
Investors
Financial Reports
Regulatory Filings
Stock Information
Press Releases
Calendar of Events
Presentations
Corporate Governance
Investor Contacts
Email Sign-up
F.A.Q.

Financial Reports

Fiscal 2010

View document (PDF) Third Quarter Results
View document (PDF) Second Quarter Results
View document (PDF) First Quarter Results


Fiscal 2009

View document (PDF)

Annual Report 2009
View document (PDF) Third Quarter Results

View document (PDF)

Second Quarter Results
View document (PDF) First Quarter Results


 Fiscal 2008

View document (PDF)

Annual Report 2008

View document (PDF)

Year End 2008

View document (PDF)

Third Quarter Results

View document (PDF)

Second Quarter Results
View document (PDF) First Quarter Results


Fiscal 2007

View document (PDF)

Annual Report 2007

View document (PDF)

Third Quarter Results

View document (PDF)

Second Quarter Results
View document (PDF) First Quarter Results // Restated
View document (PDF) First Quarter Results


Fiscal 2006

View document (PDF)

Annual Report 2006

View document (PDF)

Third Quarter Results

View document (PDF)

Second Quarter Results
View document (PDF) First Quarter Results


Fiscal 2005

View document (PDF)

Annual Report 2005

View document (PDF)

Third Quarter Results

View document (PDF)

Second Quarter Results
View document (PDF) First Quarter Results


Fiscal 2004

View document (PDF)

Annual Report 2004

View document (PDF)

Third Quarter Results

View document (PDF)

Second Quarter Results
View document (PDF) First Quarter Results


Fiscal 2003

View document (PDF)

Annual Report 2003

View document (PDF)

Third Quarter Results

View document (PDF)

Second Quarter Results
View document (PDF) First Quarter Results


Fiscal 2002

View document (PDF)

Annual Report 2002

View document (PDF)

Third Quarter Results

View document (PDF)

Second Quarter Results
View document (PDF) First Quarter Results


View other YM BioSciences public documents at www.sedar.com.

© 2009 YM BioSciences Inc.       privacy policy       legal disclaimer       home
events
news
presentations
financial reports
email sign-up